Publications

Saxena, T., Guedes, G., Domingues, I., Yagoubi, H., Guilbaud, L., Van den Bossche, W., Pangua, C., Vande Velde, G., Ucakar, B., García-Esnaola, A., Leclercq, I., Cortajarena, A. L., & Beloqui Garcia, A. (2026). Engineered protein nanoclusters reduce liver fibrosis and hepatocellular carcinoma in mice models. Bioactive Materials, 65, 14-27. https://doi.org/10.1016/j.bioactmat.2026.05.038 (Original work published 2026)

Saxena, T., Guedes, G., Domingues, I., Yagoubi, H., Guilbaud, L., Van Den Bossche, W., Pangua, C., Vande Velde, G., Ucakar, B., García-Esnaola, A., Leclercq, I., Cortajarena, A., & Beloqui, A. (2026). Engineered protein nanoclusters reduce liver fibrosis and hepatocellular carcinoma in mice models. Bioactive Materials. Submitted. https://doi.org/10.1016/j.bioactmat.2026.05.038 (Original work published 2026)

Kleinert, M.-L., Atighetchi, S., Beck, J., Bolt, L., Stalder, O., Romskaug, R., Callegari, E., Fernández Maldonado, L., Miralles Basseda, R., Kaznowski, M., Wichniak, A., Tsoutsi, V., Kollia, P., De Saint-Hubert, M., Spinewine, A., Rodondi, N., & Aubert, C. (2026). Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care (BE-SAFE): study protocol of a cluster randomised controlled trial. BMJ Open, 16(10), e123804. https://doi.org/10.1136/bmjopen-2026-123804 (Original work published 2026)

Leone, G., Akoumia, K. K. F., Ucakar, B., Esfahani, H., Perros, F., Frédérick, R., Dessy, C., & Vanbever, R. (2026). Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery. Journal of Controlled Release, 398, 115247. https://doi.org/10.1016/j.jconrel.2026.115247 (Original work published 2026)

Ackermans, L., Van Durme, T., De Saint-Hubert, M., Guisset, S., Van Leeuwen, E., Coteur, K., Tommelein, E., Philippe, G., Dilles, T., Verschuren, S., De Vriese, C., Patris, S., Siriez, R., Vanpee, D., & Spinewine, A. (2026). Self-Perceived Competencies, Knowledge, Skills, and Attitudes of Healthcare Professional Students in Deprescribing: A National Survey. Journal of General Internal Medicine. Published. https://doi.org/10.1007/s11606-026-10724-9 (Original work published 2026)

Amadieu, C., Garin, H., Bukowski, H., Ahmed, H., Kärkkäinen, O., Nicaise, P., Lorant, V., Maurage, P., Leyrolle, Q., Clergue-Duval, V., Bindels, L., Neyrinck, A., Hanhineva, K., Starkel, P., Delzenne, N., Leclercq, S., & de Timary, P. (2026). Gut microbiota heterogeneity is linked to social dysfunction in severe alcohol use disorder. Microbiome. Published. https://doi.org/10.1186/s40168-026-02474-x (Original work published 2026)

de Terwangne, C., Henrard, S., Marien, S., Steinman, M., Boland, B., & Christiaens, A. (2026). Diabetes overtreatment and flags for deprescribing glucose‐lowering treatment in geriatric inpatients with type 2 diabetes: Prognostic insights from a longitudinal cohort. Diabetic Medicine: journal of diabetes UK, 1-10. https://doi.org/10.1111/dme.70435 (Original work published 2026)

Kumar, P., Chakraborty, A., Richter, E., Yang, L., Schröppel, A., Mergault, C., Blayac, M., Vanbever, R., Plantier, L., Heuzé-Vourch, N., & Schmid, O. (2026). Microliter-scale in vitro aerosol-cell delivery of inhalable antisense oligonucleotide (aso) induces “Burst-like” Pharmacokinetics. International Journal of Pharmaceutics:, 100588. https://doi.org/10.1016/j.ijpx.2026.100588 (Original work published 2026)

Achamrah, N., Breton, J., Galmiche, M., Demangeat, T., Quillard, M., Grigioni, S., Folope, V., Lelandais, H., Coëffier, M., Bindels, L., Déchelotte, P., Tavolacci, M.-P., & Ribet, D. (2026). Characterization of changes in the gut microbiota associated with eating disorders. Clinical Nutrition, 62, 106681 [1-14]. https://doi.org/10.1016/j.clnu.2026.106681 (Original work published 2026)

Hendrickx, P. B. M., des Rieux, A., & Bastings, M. M. C. (2026). Tunable Lipid Coatings Enable Cytoplasmic siRNA Delivery by DNA Origami. ACS Applied Materials and Interfaces, 18(25), 34778-34789. https://doi.org/10.1021/acsami.6c03188 (Original work published 2026)

Debuisson, F., Ucakar, B., Vanvarenberg, K., Loll, F., Le Visage, C., Santos, A., Mwema, A., & des Rieux, A. (2026). Advanced microfluidic strategy for In-Bead MSC spheroid formation and co-encapsulation of necrosis inhibitor-loaded nanoparticles. Accepted/in-press. https://doi.org/10.64898/2026.06.14.732109 (Original work published 2026)

Barbé, A., Boland, L., Kanaan, N., Darius, T., Buemi, A., France, Y., Ronsyn, M.-A., Rahal, S., Lingurski, M., Van Bambeke, F., Bindels, L., Haufroid, V., Elens, L., & Devresse, A. (2026). ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiome modulations After kidney transplantation (ENIGMA): study protocol of a prospective longitudinal trial. BMJ Open, 16(6), e106623 [1-8]. https://doi.org/10.1136/bmjopen-2025-106623 (Original work published 2026)

Rodella, G., Pesce, C., Rampado, R., Garofalo, M., Wang, M., Ucakar, B., Vanvarenberg, K., Ma, Z., Joudiou, N., Préat, V., Gallez, B., & Malfanti, A. (2026). Localized delivery of hyaluronic acid-doxorubicin from a surgical paste for post-operative glioblastoma treatment. Materials Today Bio, 38, 103142. https://doi.org/10.1016/j.mtbio.2026.103142 (Original work published 2026)

Autuori, M., Neyrinck, A., Lengele, L., Viera Olivera, E., Rombaux, M., Rodriguez, J., Cani, P., Walter, J., Bindels, L., & Delzenne, N. (2026). Breath volatilome analysis reveals new gut microbiome-related metabolites that discriminate high versus low dietary fibre intake. Clinical Nutrition, 61, 106662 [1-13]. https://doi.org/10.1016/j.clnu.2026.106662 (Original work published 2026)

Sovegnon, T., Fagla, S. M., Legba, B. B., Lorent, J., Quetin-Leclercq, J., Ganfon, H., Klotoe, J.-R., Gbaguidi, F., & Dougnon, V. (2026). Integrated In Silico Prioritization of Antidiabetic Phytochemicals from P. Beauv. Based on Docking, Induced-Fit Docking, QSAR, and ADMET Analyses. Molecules, 31(11), 1879 [1-35]. https://doi.org/10.3390/molecules31111879 (Original work published 2026)

Lengele, L., Autuori, M., Bosteels, E., Neyrinck, A., Rombaux, M., Cani, P., Dormal, V., Deldicque, L., Bindels, L., & Delzenne, N. (2026). Link between ultra-processed foods and drinks intake, gut microbiota and inflammation: an exploratory analysis in adult volunteers. Nutrition journal. Accepted/in-press. https://doi.org/10.1186/s12937-026-01340-8 (Original work published 2026)

Fuchs, V., Zerah, L., Spinewine, A., & Henrard, S. (2026). Drug-drug interactions with direct oral anticoagulants in Belgian primary care patients with non-valvular atrial fibrillation. Scientific Reports, 16(1), 1-11. https://doi.org/10.1038/s41598-026-53817-5 (Original work published 2026)

Morigny, P., Ji, H., Cussonneau, L., Zorzato, S., Kwon, Y., Riols, F., Kaltenecker, D., Maier, A., Karthikaisamy, V., Corrà, S., Krauss, T., Seeliger, C., Gillani, S. Q., Tissink, J. J., Lacas-Gervais, S., Samanci, T. F., Maida, A., Terron-Exposito, R., Trinca, A., et al. (2026). Inhibition of ceramide synthesis ameliorates body wasting in a cancer cachexia model. Journal of Clinical Investigation, 136(10), e194687 [1-18]. https://doi.org/10.1172/JCI194687 (Original work published 2026)

Montenegro, J., Oliveira, C. L., Nguyen, N. K., Armet, A. M., Berg, A., Sharma, A. M., Mereu, L., Cominetti, C., Ghosh, S., Cani, P., Richard, C., Walter, J., & Prado, C. M. (2026). The Effects of a Powdered Meal Replacement on Inflammation, Gut Microbiota, and Metabolism in People With Excess Body Weight-A Randomized Controlled Trial. The Journal of Nutrition, 156(7), 101595. https://doi.org/10.1016/j.tjnut.2026.101595 (Original work published 2026)

Spinewine, A., Evrard, P., Nevins, P., Adda, T., Vanderhout, S., Branje, K., Hutton, J., Smith, M., Taljaard, M., & Nicholls, S. G. (2026). Patient and public involvement in pragmatic trials with older adults: a multi-methods study of researchers’ experiences. BMC Geriatrics, 26(1), 891. https://doi.org/10.1186/s12877-026-07619-z (Original work published 2026)

Forest, E., Lehoux, J., Faion, L., Ranava, D., Mohymont, V., Durand, T., Audebert, S., Camoin, L., Crauste, C., Canaan, S., Brunel, J. M., Van Bambeke, F., Bolla, J.-M., & Cavalier, J.-F. (2026). Oxadiazolone Derivatives: Powerful Tools to Reduce Staphylococcus aureus Infection. ACS Infectious diseases. Accepted/in-press. https://doi.org/10.1021/acsinfecdis.6c00165 (Original work published 2026)

Gilliard, G., Pršić, J., Crowet, J.-M., Chemotti, C., Ahmed, J., Lorent, J., Jolivet, M.-D., Egli, S., Egée, S., Bouyer, G., Race, G., van Buren, L., Van Den Berghe, A., Argüelles-Arias, A., Mathelié-Guinlet, M., Ibrahim, H., Genva, M., Fouillen, L., Mirande-Bret, C., et al. (2026). Membrane remodelling mediates lipopeptide-induced immunity in Arabidopsis. Nature Plants, 12(5), 1034-1050. https://doi.org/10.1038/s41477-026-02270-3 (Original work published 2026)

Roumain, M., & Muccioli, G. (2026). Oxysterols and bile acids - From intertwined biosynthesis to combined quantification. Progress in Lipid Research, 102, 101385 [1-19]. https://doi.org/10.1016/j.plipres.2026.101385 (Original work published 2026)

Stavart, C., Gohy, S., Lebeer, S., Van Bambeke, F., Crabbé, A., & Pilette, C. (2026). Crosstalk between the microbiome and the mucosal immunoglobulin A system in the lung, in health and disease. Frontiers in Cellular and Infection Microbiology, 16, 1796523. https://doi.org/10.3389/fcimb.2026.1796523 (Original work published 2026)

Delzenne, N., Autuori, M., & Neyrinck, A. (2026). Breath volatilome as a non-invasive reflection of gut microbiota-driven health and disease. Cell Metabolism, 38(4), 638-640. https://doi.org/10.1016/j.cmet.2026.03.007 (Original work published 2026)

Niyigena, E., Hoffert, Y., Afif, W., Pedicelli, A., Roblin, X., Hanžel, J., Papamichael, K., Kobayashi, T., Elens, L., Wang, Z., Ferrante, M., Verstockt, B., Vermeire, S., Vande Casteele, N., Battat, R., & Dreesen, E. (2026). Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis. Journal of Crohn’s and Colitis, 20(3), jjag029. https://doi.org/10.1093/ecco-jcc/jjag029 (Original work published 2026)

Mamede, L., Rangel, G. W., Schmitt, M., Albrecht, S., Spichty, M., Bero, J., Beaufay, C., Florent, I., Llinás, M., Frédérich, M., & Quetin-Leclercq, J. (2026). Natural triterpenic phenolic esters target PfA-M17 in Plasmodium falciparum. Malaria Journal, 25(1), 74 [1-11]. https://doi.org/10.1186/s12936-025-05762-3 (Original work published 2026)

Varik, V., Wang, G., Kritikos, G., Banzhaf, M., Drouot, E., Koumoutsi, A., & Van Bambeke, F. (2026). Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages. Antimicrobial Agents and Chemotherapy, 70(1), e0131925. https://doi.org/10.1128/aac.01319-25 (Original work published 2026)

Magedanz, L., Galato, D., Apornak, A., Magennis, B., Triki, C. C., Anene-Okeke, C. G., Beavers, C. J., Doucette, D., Pitters, E., Lloyd, G. F., Davidson, G., Lopes, H., Pawłowska, I., Miguens Blanco, I., Ng, J., Wanigasinghe, J., Burman, J., Toombs, K., Pinto, L. F., et al. (2026). Key performance indicators for hospital clinical pharmacy services: results of a global Delphi study. International Journal of Clinical Pharmacy. Published. https://doi.org/10.1007/s11096-026-02126-y (Original work published 2026)

Bestard-Escalas, J., Sasportes, O., Ameraoui, H., González-Nicolau, M., Al Houayek, M., & Muccioli, G. (2026). The endocannabinoid-derived prostaglandin glycerol esters and prostaglandin ethanolamides modulate intestinal epithelial hallmarks of colitis. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1871(2), 159719. https://doi.org/10.1016/j.bbalip.2026.159719 (Original work published 2026)

Briquet, C., Ngougni Pokem, P., Liu, X., Wijnant, G.-J., Cornu, O., Yildiz, H., Verroken, A., Roberts, J., Yombi, J. C., & Van Bambeke, F. (2026). A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patients. Antimicrobial Agents and Chemotherapy, 70, e0037226. (Original work published 2026)

Bussières, J.-F., Voirol, P., Perrottet, N., Spinewine, A., Bengaly, L., El Cadi, M. A., Ouedraogo, E. W., Ben Jeddou, K., Rakotonirina, F. M. V., & Décaudin, B. (2026). Profil des stages de formation offerts en pharmacie clinique en établissement de santé : une étude exploratoire Nord-Sud. Annales Pharmaceutiques Francaises, 84(5), 906-917. https://doi.org/10.1016/j.pharma.2026.02.010 (Original work published 2026)

del Olmo, R., Revilla, R. I., Debuisson, F., Baert, K., Van Hooreweder, B., des Rieux, A., De Graeve, I., & Santos-Coquillat, A. (2026). Synergistic effects of etching and electropolishing on additively manufactured Ti-6Al-4V scaffolds for biomedical implants. Additive Manufacturing, 116, 105083. https://doi.org/10.1016/j.addma.2026.105083 (Original work published 2026)

Guillou, A., Joudiou, N., Fortin, A., Gourand, F., Mignion, L., Jordan, B., Cahard, D., & Perrio, C. (2026). A dual-modal F MRI/F PET approach using sultone-derived chemical tags. The Analyst, 151(7), 1970-1977. https://doi.org/10.1039/d5an01102g (Original work published 2026)

Luyens, B., Felgueroso-Bueno, F., Everard, A., & Massat, I. (2026). Gut-brain axis in Attention Deficit Hyperactivity Disorder (ADHD): A narrative review of the links between gut microbiota and ADHD pathophysiology. Journal of Psychiatric Research, 195, 199-211. https://doi.org/10.1016/j.jpsychires.2026.01.038 (Original work published 2026)

Marco, M. L., Cunningham, M., Bischoff, S. C., Clarke, G., Delzenne, N., Lewis, J. D., Meisel, M., Merenstein, D., O’Toole, P. W., Staudacher, H. M., Szajewska, H., Wells, J. M., & Quigley, E. M. M. (2026). The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health. Nature Reviews Gastroenterology & Hepatology, 1-17. https://doi.org/10.1038/s41575-026-01176-x (Original work published 2026)

Schioppa, L., Michalowski, C. B., Mamede, L., Terrasi, R., Herent, M.-F., Muccioli, G., Frédérick, R., Frederich, M., Beloqui Garcia, A., & Quetin-Leclercq, J. (2026). Antiparasitic triterpenic ester and ursolic acid lipid nanocapsule design, cytotoxicity, and permeability evaluation for oral delivery. Frontiers in drug delivery, 6, 1846904 [1-12]. https://doi.org/10.3389/fddev.2026.1846904 (Original work published 2026)

Louis, M.-H., Legrain, V., Aron, V., Filbrich, L., Mouraux, A., Henrard, S., Guillaume, L., Mouraux, D., Barbier, O., Libouton, X., & Berquin, A. (2026). Complex regional pain syndrome evolution is determined by both biological and psychosocial factors: a 1-year prospective observational study. PAIN®, 167(2), 396-431. https://doi.org/10.1097/j.pain.0000000000003815 (Original work published 2026)

Huschka, J., Jungo, K. T., Aponte Ribero, V., Brockhus, L., O’Mahony, D., Randles, M., Marien, S., Drenth, C., Spinewine, A., Knol, W., Aujesky, D., Rodondi, N., & Aubert, C. E. (2026). Trends over time and risk factors in inappropriate prescribing in older adults with multimorbidity and polypharmacy: a longitudinal secondary analysis of the OPERAM trial. Swiss Medical Weekly, 156(2), 1-17. https://doi.org/10.57187/4892 (Original work published 2026)

Ward, B., Balligand, J.-L., Bindels, L., Cani, P., Bearzatto, B., Bommer, G., Dewulf, J., De Greef, J., Gatto, L., Kabamba-Mukadi, B., Jodogne, S., Haufroid, V., Pyr dit Ruys, S., Vertommen, D., Yombi, J. C., Belkhir, L., & Elens, L. (2026). Association of nasopharyngeal and species with post-acute sequelae of SARS-CoV-2 in a longitudinal cohort. Microbiology Spectrum, 14(4), e0231325 [1-14]. https://doi.org/10.1128/spectrum.02313-25 (Original work published 2026)

Buzisa Mbuku, R., Poilvache, H., Maigret, L., Vanbever, R., Van Bambeke, F., & Cornu, O. (2026). Enzymes-enhanced antibiotic therapy reduces biofilms to undetectable levels in an implant-associated infection model. NPJ biofilms and microbiomes, 12(1), 44 [1-15[. https://doi.org/10.1038/s41522-026-00910-2 (Original work published 2026)

Paone, P., Petitfils, C., Puel, A., Latousakis, D., de Vos, W. M., Delzenne, N. M., Juge, N., Van Hul, M., & Cani, P. D. (2026). . Gut microbes, 18(1), 2612580. https://doi.org/10.1080/19490976.2025.2612580 (Original work published 2026)

Ide, A., Vellemans, S., Chadare, F. J., Ho, P. Y., Warnant, A., Mignolet, E., Quetin-Leclercq, J., Assogbadjo, A., Debier, C., Feron, O., & Yvan Larondelle. (2026). Traditional seed dehulling practices promote oxidation of Ricinodendron heudelotii kernel oil rich in conjugated linolenic acids. Journal of Food Composition and Analysis, 153(109160), 10. https://doi.org/10.1016/j.jfca.2026.109160 (Original work published 2026)

Ma, Z., Dang, H. A., Yang, J., Rodella, G., Mwema, A., De Lombaerde, Chen, Y., De Geest, B. G., Van Pesch, V., Muccioli, G., & des Rieux, A. (2026). Lipid nanoparticle-mediated delivery of microRNA-124 reduces neuroinflammation. Biomaterials, 325, 123589. https://doi.org/10.1016/j.biomaterials.2025.123589 (Original work published 2026)

Lee, C.-H., Bui, T. P. N., Petitfils, C., Jian, C., Wong, G. C., Puel, A., Le Roy, T., Bellais, S., Ben Abdallah, B., Nehlich, M., Leicht, T., Jia, M., Hoyles, L., Federici, M., Fernández-Real, J. M., Burcelin, R., Dumas, M.-E., Delzenne, N., Clavel, T., et al. (2026). Novel -inositol to butyrate fermentation pathway in the prevalent human gut species a bacterium associated with improved metabolic and liver health. Gut, 75(7), 1338-1352. https://doi.org/10.1136/gutjnl-2025-336617 (Original work published 2026)

Van Hul, M., & Cani, P. (2026). From microbiome to metabolism: Bridging a two-decade translational gap. Cell Metabolism, 38, 1-19. https://doi.org/10.1016/j.cmet.2025.10.011 (Original work published 2026)

Shostak, K., Chen, Y., Maurizy, C., Rademaker, G., Xu, X., Blomme, A., Close, P., Renson, O., Van Hul, M., Cani, P., Klein, S., Florin, A., Büttner, R., Cataldo, D., Delvenne, P., Nemazanyy, I., Wathieu, C., Hego, A., Ormenese, S., et al. (2026). The lipid transfer protein STARD7 controls intestinal tumor development in a context-dependent manner. EMBO Molecular Medicine. Accepted/in-press. https://doi.org/10.1038/s44321-026-00409-5 (Original work published 2026)

Chen, C., Guilbaud, L., Marotti, V., Zhang, W., Ladeiro Domingues, I., Yagoubi, H., Vints, K., Xu, Y., & Beloqui Garcia, A. (2026). An antioxidant metal-organic framework with functional coatings for oral anti-TNF-α antibody delivery in inflammatory bowel disease treatment. Journal of Controlled Release, 389, 114411. https://doi.org/10.1016/j.jconrel.2025.114411 (Original work published 2026)

Moura Rui Pedro, Mwema, A., Bottemanne, P., Pêgo, A. P., Sarmento, B., Ucakar, B., Muccioli, G., Vanvarenberg, K., & des Rieux, A. (2026). Therapeutic potential of retinoic acid-loaded lipid Nanocapsules in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Journal of Controlled Release, 393, 114804. https://doi.org/10.1016/j.jconrel.2026.114804 (Original work published 2026)

Lecomte, E., Arys, M., Christiaens, A., Doyen, L., Marot, J., Verbelen, V., & Wieërs, G. (2026). Prioritizing cefuroxime as empirical treatment in acute bacterial prostatis: patient characteristics and outcomes. JAC Antimicrobial Resistance. Accepted/in-press. (Original work published 2026)

Louis, M.-H., Legrain, V., Aron, V., Filbrich, L., Henrard, S., Mouraux, A., & Berquin, A. (2026). CRPS evolution is determined by both biological and psychosocial factors – a 1-Year prospective observational study. PAIN®, 167(4), 991-992. https://doi.org/10.1097/j.pain.0000000000003877 (Original work published 2026)

Morelle, A., Dechenne, J., Caruano, J., Vander Auwera, O., Barozzino‐Consiglio, G., Michaux, C., Muccioli, G., & Robiette, R. (2026). Toward a Better Understanding of Fatty Acid Amide Hydrolase Inhibition by β‐Lactams. Chemistry & Biodiversity, e02705. https://doi.org/10.1002/cbdv.202502705 (Original work published 2025)

Morigny, P., Vondrackova, M., Ji, H., Brejchova, K., Krakovkova, M., Makris, K., Trubacova, R., Samanci, T. F., Kaltenecker, D., Ng, S.-P., Karthikaisamy, V., Chrysostomou, S. E., Bidovec, A., Ponce-de-Leon, M., Krauss, T., Seeliger, C., Prokopchuk, O., Martignoni, M. E., Claussnitzer, M., et al. (2026). Multi-omics profiling of cachexia-targeted tissues reveals a spatio-temporally coordinated response to cancer. Nature Metabolism, 1-47. https://doi.org/10.1038/s42255-025-01434-3 (Original work published 2026)

del Olmo, R., Revilla, R. I., Debuisson, F., Baert, K., Van Hooreweder, B., Rieux, A. d., De Graeve, I., & Santos-Coquillat, A. (2026). Synergistic effects of etching and electropolishing on additively manufactured Ti-6Al-4V scaffolds for biomedical implants. Additive Manufacturing, 116, 105083. https://doi.org/10.1016/j.addma.2026.105083 (Original work published 2026)

Degraeve, A., Cutignano, A., Piscitelli, F., Villano, R., De Simone, G., Verde, R., Thibaut, M., Bindels, L., & Di Marzo, V. (2026). Changes in levels of endocannabinoidome mediators in mice with cancer cachexia: links with steatosis and gut microbial dysbiosis. BJC reports, 4(1), 7 [1-12]. https://doi.org/10.1038/s44276-026-00208-y (Original work published 2026)

Gallez, B. (2026). Electron paramagnetic resonance (EPR) meets drug delivery and biomaterials: a magnetic love story. Drug Delivery and Translational Research, 16(7), 2350-2366. https://doi.org/10.1007/s13346-025-01992-9 (Original work published 2026)

Dufour, I., Fernandes, G., meijers, B., Labriola, L., Goffin, E., & Bindels, L. (2026). Cachexia in Chronic Kidney Disease: A role for the Gut Microbiome? Submitted. (Original work published 2026)

Aponte Ribero, V., Efthimiou, O., Alwan, H., Bauer, D. C., Henrard, S., Waeber, G., Marques-Vidal, P., Rodondi, N., Del Giovane, C., & Gencer, B. (2026). Development and validation of the CARE-DM model to predict the cardiovascular risk in older persons with type 2 diabetes. European Journal of Preventive Cardiology, 33(1), 44-52. https://doi.org/10.1093/eurjpc/zwaf296 (Original work published 2026)